Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endostatin in Neurofibromatosis Type 2 (NF2)
NCT02104323Phase 2Completed
- Sponsor
- Beijing Tiantan Hospital
- Start
- Jan 2014
- Primary completion
- Apr 2016
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of endostar in neurofibromatosis type 2 (NF2), sponsored by Beijing Tiantan Hospital. Primary endpoint: Change from Baseline in volume of tumour at Month 11. Started Jan 2014; status: completed.
02
Drugs
endostar
03
Conditions
neurofibromatosis type 2 (NF2)
Beyond the preview
Go deeper on NCT02104323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02104323.